HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takeshi Kawamura Selected Research

VATER association

1/2015Urinary reconstruction in vertebral, anorectal, cardiac, trachea-esophageal, renal abnormalities and limb defects association with chronic renal failure and penile duplication.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takeshi Kawamura Research Topics

Disease

13Neoplasms (Cancer)
01/2022 - 07/2010
8Inflammation (Inflammations)
01/2019 - 01/2002
6COVID-19
05/2022 - 03/2021
4Leukemia
01/2021 - 04/2014
4Lung Neoplasms (Lung Cancer)
12/2015 - 04/2010
3Infections
02/2022 - 10/2002
3Proteinuria
07/2010 - 01/2005
2Carcinoma (Carcinomatosis)
01/2022 - 01/2021
2Wilms Tumor (Wilm's Tumor)
11/2021 - 11/2013
2Thrombosis (Thrombus)
03/2020 - 06/2016
2Neutropenia
01/2020 - 01/2019
2Body Weight (Weight, Body)
06/2019 - 05/2015
2Diabetes Mellitus
06/2019 - 07/2018
2Diabetic Nephropathies (Diabetic Nephropathy)
06/2019 - 07/2018
2Hypertension (High Blood Pressure)
06/2019 - 07/2018
2Liver Failure
01/2019 - 04/2012
2Adenocarcinoma of Lung
12/2015 - 04/2010
2Ascites
08/2011 - 10/2010
2Liposarcoma
08/2011 - 01/2011
2Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
07/2010 - 01/2005
1Arthralgia (Joint Pain)
01/2022
1Fever (Fevers)
01/2022
1Virus Diseases (Viral Diseases)
06/2021
1Hypoxia (Hypoxemia)
01/2021
1Type 2 von Willebrand Disease
03/2020
1Immunoglobulin G4-Related Disease
10/2019
1MYH9-Related Disorders
04/2019
1Hemorrhage
04/2019
1Viremia
01/2019
1Colonic Neoplasms (Colon Cancer)
01/2016
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016
1Pulmonary Hypertension
01/2016

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
05/2022 - 08/2007
7Immunoglobulin G (IgG)IBA
05/2022 - 10/2019
5Immunoglobulin M (IgM)IBA
05/2022 - 01/2005
3AntibodiesIBA
05/2022 - 01/2019
3Rituximab (Mabthera)FDA Link
01/2019 - 12/2006
3Messenger RNA (mRNA)IBA
01/2016 - 02/2010
3EnzymesIBA
08/2007 - 01/2002
2Immunoglobulin A (IgA)IBA
05/2022 - 02/2022
2VaccinesIBA
05/2022 - 03/2022
2Neutralizing AntibodiesIBA
05/2022 - 01/2016
2Viral ProteinsIBA
02/2022 - 06/2021
2LigandsIBA
01/2016 - 06/2012
2Formaldehyde (Formol)FDA Link
12/2015 - 04/2010
2ParaffinIBA
12/2015 - 04/2010
2Cisplatin (Platino)FDA LinkGeneric
08/2011 - 10/2010
1NucleoproteinsIBA
05/2022
1Nucleocapsid ProteinsIBA
02/2022
1iminobiotinIBA
01/2022
1human ERBB2 proteinIBA
01/2022
1silicon phthalocyanineIBA
01/2022
1IntegrinsIBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1AntipyreticsIBA
01/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
16-methyladenineIBA
11/2021
1N-methyladenosineIBA
11/2021
1RNA (Ribonucleic Acid)IBA
11/2021
1CohesinsIBA
06/2021
1ChromatinIBA
06/2021
1MethyltransferasesIBA
06/2021
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
05/2021
1OligonucleotidesIBA
05/2021
1A-Form DNA (A-DNA)IBA
05/2021
1Oncogene Proteins (Oncogene Protein)IBA
01/2021
1pembrolizumabIBA
01/2021
1Translationally-Controlled 1 Tumor ProteinIBA
01/2021
1Immunologic Factors (Immunomodulators)IBA
01/2021
1Factor VIII (Coagulation Factor VIII)IBA
03/2020
1FibrinIBA
03/2020
1von Willebrand FactorIBA
03/2020
1CollagenIBA
03/2020
1Thromboplastin (Tissue Factor)IBA
03/2020
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020
1Uric Acid (Urate)IBA
06/2019
1Single-Chain AntibodiesIBA
01/2019
1AntigensIBA
01/2019
1Alanine (L-Alanine)FDA Link
01/2019
1Polycomb Repressive Complex 1IBA
05/2017
1LipidsIBA
04/2016
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2016
1Acetaminophen (Paracetamol)FDA LinkGeneric
04/2016
1Dinoprostone (PGE2)FDA Link
04/2016
1Epidermal Growth Factor (EGF)IBA
01/2016
1EpiregulinIBA
01/2016
1ErbB Receptors (EGF Receptor)IBA
01/2016
1Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
01/2016
1Biological ProductsIBA
01/2016

Therapy/Procedure

8Transplantation
06/2019 - 01/2005
8Kidney Transplantation
04/2019 - 01/2003
7Therapeutics
05/2021 - 01/2003
4Lasers (Laser)
12/2015 - 08/2007
3Drug Therapy (Chemotherapy)
01/2011 - 03/2002
2Hepatectomy
01/2019 - 04/2012
2Precision Medicine
01/2019 - 08/2007
1Immunotherapy
01/2021
1Platelet Transfusion (Blood Platelet Transfusions)
04/2019
1Perioperative Period
04/2019
1Splenectomy
01/2019